Instituto Bioclon

The Bioclon Institute is a Mexican company and came about as a result of the 1990 amalgamate of diverse biological and pharmaceutical companies. It emerged for the purpose of taking advantage of the opportunities for developing new biotechnologies and for becoming a world leader in the research, development, and production of antivenoms for stings and bites by poisonous animals, with innovation as the main resource for competitiveness.

Bioclon is the creator of third generation antivenoms on a worldwide level, whose biotechnological characteristics make them different. These antivenoms were named fabotherapics, which is a new definition for antivenoms that are highly safe, broadly efficacious, and having had no reports of severe secondary effects. They are produced using a technology that is 100% that of the Bioclon Institute, and protected by patents in several countries.

The quality of its products is one of the company's permanent goals; an example of which is the Certificación Internacional de Buenas Prácticas de Manufactura (International Certificate for Good Manufacturing Practies) which was granted to Bioclon by the Instituto Nacional de Vigilancia de Medicamentos y Alimentos, (INVIMA) (National Food and Drug Monitoring Institute), of the Ministerio de la Protección Social (Secretary of Social Protection) of Colombia, as well as by COFEPRIS, in Mexico. The Bioclon Institute is the only Mexican company that has obtained the designation "orphan drug" (the non-existence of a drug or medication for treating a specific disease) by the Food and Drug Administration (FDA) of the United States for three of its products, corroborating its worldwide leadership in the development and production of fabotherapics.

Highlighted among its efforts is the creation of the Primera Red Nacional de Centros para el Control y Tratamiento de Envenenamientos por Animales Ponzoñosos, REDTOX (First National Network for the Control and Treatment of Envenoming by Poisonous Animals (www.redtox.org). This network's purpose is to advise the medical community with regard to treatments that should be used for the timely and adequate care of patients who are bitten or stung by poisonous animals. The establishment of a community composed of researchers, biologists, and doctors who provide knowledge and experience about different poisonous animal species that inhabit the planet, the health problems that they provoke, and the mechanisms for solving them, is one of the greatest instruments for supporting the efficacious care and application of said treatments.

Calzada de Tlalpan # 4687, Col. Toriello Guerra. C.P. 14050, México D.F., Tel 56-65-41-11